This post was originally published on this site

Bioanalytical Systems (NASDAQ:BASI) announced its earnings results on Monday. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.16, Fidelity Earnings reports. Bioanalytical Systems had a negative net margin of 7.75% and a negative return on equity of 42.74%.

Shares of NASDAQ BASI traded up $2.89 on Wednesday, reaching $15.22. 406,903 shares of the company traded hands, compared to its average volume of 119,630. The company has a 50 day moving average of $12.77 and a 200 day moving average of $7.34. The stock has a market capitalization of $168.30 million, a PE ratio of -33.88 and a beta of 1.92. Bioanalytical Systems has a fifty-two week low of $3.05 and a fifty-two week high of $15.87. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 2.49.

Separately, Colliers Securities assumed coverage on shares of Bioanalytical Systems in a research note on Tuesday, December 22nd. They set a “buy” rating and a $17.00 price objective for the company.

About Bioanalytical Systems

Bioanalytical Systems, Inc, doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products.

Read More: Price Target

Receive News & Ratings for Bioanalytical Systems Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bioanalytical Systems and related companies with’s FREE daily email newsletter.